Document Detail

Oseltamivir treatment and prophylaxis in a neonatal intensive care unit during a 2009 H1N1 influenza outbreak.
MedLine Citation:
PMID:  21233797     Owner:  NLM     Status:  Publisher    
Objective:To evaluate safety of oseltamivir in neonates with significant comorbidities in a level-III neonatal intensive care unit during an outbreak of 2009 H1N1 influenza.Study Design:We performed a retrospective chart review of neonates who received oseltamivir for treatment and prophylaxis of influenza during the outbreak.Result:A total of 11 neonates received twice daily dosing and 21 neonates received once daily dosing (12 to 25 mg per dose) for treatment and prophylaxis of influenza, respectively. Age ranged from 2 days to 11.4 months (mean, 2.1 months). Corrected gestational age and weight at initiation of oseltamivir ranged from 32 to 86 weeks (mean, 41 weeks) and 775 to 8635 g (mean, 3074 g), respectively. All had complex underlying conditions. Oseltamivir was well tolerated. Neurologic adverse effects or mortality attributable to oseltamivir were not identified. Mild rash and gastrointestinal signs in four infants resolved without oseltamivir discontinuation. Three showed a transient rise in transaminases; all returned to baseline after completing therapy.Conclusion:Oseltamivir appears to be well tolerated in preterm and term neonates and infants with complex underlying conditions. More studies are needed to determine optimal dosing for treatment and prophylaxis in this vulnerable age group.Journal of Perinatology advance online publication, 13 January 2011; doi:10.1038/jp.2010.159.
P S Pannaraj; B Tam; D Akan
Related Documents :
21950397 - The role of the family in intervention of infants at high risk of cerebral palsy: a sys...
15629987 - Trends in prenatal diagnosis, pregnancy termination, and perinatal mortality of newborn...
18646077 - Erythromycin for the prevention and treatment of feeding intolerance in preterm infants.
9357357 - Thyroxine values from newborn screening of 919 infants born before 29 weeks' gestation.
9695307 - Using polymerase chain reaction for rapid sex-determination of a case of sirenomelia.
12600867 - Multiple micronutrient supplementation during pregnancy does not lead to greater infant...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-1-13
Journal Detail:
Title:  Journal of perinatology : official journal of the California Perinatal Association     Volume:  -     ISSN:  1476-5543     ISO Abbreviation:  -     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2011-1-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8501884     Medline TA:  J Perinatol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Division of Infectious Diseases, Department of Pediatrics, Keck School of Medicine, University of Southern California and Children's Hospital Los Angeles, Los Angeles, CA, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Hyperglycemia, insulin and slower growth velocity may increase the risk of retinopathy of prematurit...
Next Document:  Reversal of experimental renovascular hypertension restores coronary microvascular function and arch...